Toronto Stock Exchange · Healthcare
Invest in Curaleaf stock from India
Indian and foreign residents can buy Curaleaf (CURA) shares directly through Paasa.
By Paasa · Updated
Curaleaf at a glance
- Price
- CA$15.23-CA$0.13 (0.85%)
- Market cap
- CA$3.55B
- Day range
- CA$15.12 – CA$15.50
- P/E
- -78.64
- Dividend yield
- None
- Volume
- 26.86K
- 1 month
- +13.53%
- 6 months
- +83.75%
- YTD
- +49.27%
- 1 year
- +14.38%
- 5 years
- -66.18%
Curaleaf statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B |
| Gross profit | $498.2M | $639.2M | $614.4M | $579.0M | $687.6M |
| Operating income | $25.9M | $20.2M | $42.9M | −$10.2M | $175.6M |
| Net income | −$235.1M | −$215.4M | −$281.2M | −$376.9M | −$109.1M |
| Earnings per share | −$0.93 | −$0.87 | −$0.96 | −$1.59 | −$0.48 |
| EBITDA | $169.8M | $233.1M | $238.8M | $221.0M | $279.0M |
| Total assets | $2.8B | $2.9B | $3.1B | $3.4B | $3.1B |
| Total debt | $1.0B | $853.8M | $883.5M | $931.9M | $652.4M |
| Cash and short-term investments | $101.4M | $93.0M | $91.8M | $163.2M | $299.3M |
| Shareholders' equity | $755.0M | $861.2M | $1.1B | $1.3B | $1.5B |
| Operating cash flow | $140.3M | $162.6M | $75.3M | $46.4M | −$34.0M |
| Free cash flow | $75.8M | $64.4M | $5.0M | −$92.0M | −$205.9M |
| Capital expenditure | −$64.6M | −$98.2M | −$70.3M | −$138.4M | −$172.0M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in USD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Bausch Health Companies | BHC.TO | CA$8.18 | CA$3.06B |
| Trulieve Cannabis | TRUL.CN | $16.14 | $2.74B |
| Green Thumb Industries | GTII.CN | $11.01 | $2.52B |
| Cronos | CRON.TO | CA$4.80 | CA$1.79B |
Peers as grouped by the data provider. This is not an investment recommendation.
Analyst price targets
- Low
- —
- High
- —
- Median
- —
- Consensus
- —
Ratings: 5 buy · 2 hold · 0 sell. Consensus: Buy.
Published sell-side 12-month targets in CAD, aggregated by the data provider. They are not Paasa's view and not a forecast.
How to invest in Curaleaf from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CAD when you buy.
Step 3
Search CURA and buy
Find Curaleaf by name or by its ticker, CURA, and place your order.
Why invest in Curaleaf from India
What Curaleaf does
Curaleaf Holdings, Inc. operates as a prominent cannabis company primarily within the United States, managing its business through both domestic and international operating segments. The company's core activities involve the cultivation, production, and distribution of a diverse range of cannabis products, available through both its retail locations and wholesale channels. Curaleaf operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Curaleaf stock from India?
Yes. Indian residents and NRIs can buy Curaleaf (CURA) shares directly through Paasa. Curaleaf is listed on the Toronto Stock Exchange, in the Drug Manufacturers - Specialty & Generic industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
How are Curaleaf dividends taxed for Indian investors?
Curaleaf trades on the Toronto Stock Exchange but is domiciled in United States, so any withholding on its dividends follows that country's rules rather than those of Canada. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Curaleaf shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CAD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.